| PH8 | Name: | 5-phenyl-L-norvaline | Formula: | C11 H15 N O2 | SMILES: | C(O)(=O)C(N)CCCc1ccccc1 | InChi: | InChI=1S/C11H15NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8,12H2,(H,13,14)/t10-/m0/s1 | Definition date: | 2015-03-10 | Last modified: | 2024-09-27 | Release date: | 2015-04-15 | Identifier: | 5-phenyl-L-norvaline |
|
| Q93 | Name: | (1R,2R,3S,4S)-3-[4-(4-fluorophenyl)piperazine-1-carbonyl]bicyclo[2.2.1]heptane-2-carboxylic acid | Formula: | C19 H23 F N2 O3 | SMILES: | O=C(C1C(C(=O)O)C2CCC1C2)N1CCN(CC1)c1ccc(F)cc1 | InChi: | InChI=1S/C19H23FN2O3/c20-14-3-5-15(6-4-14)21-7-9-22(10-8-21)18(23)16-12-1-2-13(11-12)17(16)19(24)25/h3-6,12-13,16-17H,1-2,7-11H2,(H,24,25)/t12-,13+,16-,17+/m0/s1 | Definition date: | 2022-06-02 | Last modified: | 2024-09-27 | Release date: | 2022-07-06 | Identifier: | (1R,2R,3S,4S)-3-[4-(4-fluorophenyl)piperazine-1-carbonyl]bicyclo[2.2.1]heptane-2-carboxylic acid |
|
| RGI | Name: | METHYLCARBAMIC ACID | Formula: | C2 H5 N O2 | SMILES: | O=C(O)NC | InChi: | InChI=1S/C2H5NO2/c1-3-2(4)5/h3H,1H3,(H,4,5) | Definition date: | 2002-06-19 | Last modified: | 2024-09-27 | Identifier: | methylcarbamic acid |
|
| AGD | Name: | 3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-D-alanine | Formula: | C8 H10 N6 O3 | SMILES: | O=C(O)C(N)Cn1c2N=C(NC(=O)c2nc1)N | InChi: | InChI=1S/C8H10N6O3/c9-3(7(16)17)1-14-2-11-4-5(14)12-8(10)13-6(4)15/h2-3H,1,9H2,(H,16,17)(H3,10,12,13,15)/t3-/m1/s1 | Definition date: | 2008-02-12 | Last modified: | 2024-09-27 | Identifier: | 3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-D-alanine |
|
| QNW | Name: | 3-methylcatechol cysteine | Formula: | C10 H13 N O4 S | SMILES: | Cc1ccc(SC[CH](N)C(O)=O)c(O)c1O | InChi: | InChI=1S/C10H13NO4S/c1-5-2-3-7(9(13)8(5)12)16-4-6(11)10(14)15/h2-3,6,12-13H,4,11H2,1H3,(H,14,15)/t6-/m0/s1 | Definition date: | 2020-07-08 | Last modified: | 2024-09-27 | Release date: | 2020-12-23 | Identifier: | (2~{R})-2-azanyl-3-[4-methyl-2,3-bis(oxidanyl)phenyl]sulfanyl-propanoic acid |
|
| PHA | Name: | PHENYLALANINAL | Formula: | C9 H11 N O | SMILES: | O=CC(N)Cc1ccccc1 | InChi: | InChI=1S/C9H11NO/c10-9(7-11)6-8-4-2-1-3-5-8/h1-5,7,9H,6,10H2/t9-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-3-phenylpropanal |
|
| TJ7 | Name: | (2R,4S)-2-[(1S)-1-{[(2R)-2-carboxy-2-(thiophen-3-yl)acetyl]amino}-1-methoxy-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4
-carboxylic acid | Formula: | C16 H20 N2 O7 S2 | SMILES: | O=CC(OC)(C1SC(C(N1)C(O)=O)(C)C)NC(=O)C(C(O)=O)c2cscc2 | InChi: | InChI=1S/C16H20N2O7S2/c1-15(2)10(13(23)24)17-14(27-15)16(7-19,25-3)18-11(20)9(12(21)22)8-4-5-26-6-8/h4-7,9-10,14,17H,1-3H3,(H,18,20)(H,21,22)(H,23,24)/t9-,10+,14-,16+/m1/s1 | Synonyms: | temocillin | Definition date: | 2019-10-15 | Last modified: | 2024-09-27 | Release date: | 2019-10-30 | Identifier: | (2R,4S)-2-[(1S)-1-{[(2R)-2-carboxy-2-(thiophen-3-yl)acetyl]amino}-1-methoxy-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
| P23 | Name: | PROPYL TRIHYDROGEN DIPHOSPHATE | Formula: | C3 H10 O7 P2 | SMILES: | O=P(O)(OP(=O)(OCCC)O)O | InChi: | InChI=1S/C3H10O7P2/c1-2-3-9-12(7,8)10-11(4,5)6/h2-3H2,1H3,(H,7,8)(H2,4,5,6) | Definition date: | 2004-07-01 | Last modified: | 2024-09-27 | Identifier: | propyl trihydrogen diphosphate |
|
| O | Name: | OXYGEN ATOM | Formula: | O | SMILES: | O | InChi: | InChI=1S/H2O/h1H2 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | water |
|
| R2T | Name: | beta,gamma-dihydroxyglutamine | Formula: | C5 H10 N2 O5 | SMILES: | O=C(N)C(O)C(O)C(C(=O)O)N | InChi: | InChI=1S/C5H10N2O5/c6-1(5(11)12)2(8)3(9)4(7)10/h1-3,8-9H,6H2,(H2,7,10)(H,11,12)/t1-,2+,3-/m0/s1 | Definition date: | 2014-01-29 | Last modified: | 2024-09-27 | Release date: | 2014-05-07 | Identifier: | (2S,3R,4S)-2,5-diamino-3,4-dihydroxy-5-oxopentanoic acid (non-preferred name) |
|
| KY7 | Name: | {(4Z)-2-[(1S)-1-amino-2-sulfanylethyl]-4-[(4-hydroxy-3-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C14 H14 N4 O6 S | SMILES: | NC(CS)C1=N/C(C(N1CC(=O)O)=O)=Cc2cc(c(cc2)O)[N+](=O)[O-] | InChi: | InChI=1S/C14H14N4O6S/c15-8(6-25)13-16-9(14(22)17(13)5-12(20)21)3-7-1-2-11(19)10(4-7)18(23)24/h1-4,8,19,25H,5-6,15H2,(H,20,21)/b9-3-/t8-/m1/s1 | Synonyms: | CHROMOPHORE (CYS-TYR-GLY)-3-NO2 | Definition date: | 2019-01-23 | Last modified: | 2024-09-27 | Release date: | 2019-06-12 | Identifier: | {(4Z)-2-[(1S)-1-amino-2-sulfanylethyl]-4-[(4-hydroxy-3-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| TJ8 | Name: | 2-bromanyl-4-(2-phenylimidazol-1-yl)benzaldehyde | Formula: | C16 H11 Br N2 O | SMILES: | Brc1cc(ccc1C=O)n2ccnc2c3ccccc3 | InChi: | InChI=1S/C16H11BrN2O/c17-15-10-14(7-6-13(15)11-20)19-9-8-18-16(19)12-4-2-1-3-5-12/h1-11H | Synonyms: | LvD1009 | Definition date: | 2020-12-22 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 2-bromanyl-4-(2-phenylimidazol-1-yl)benzaldehyde |
|
| QNX | Name: | [(2~{S})-3-(1~{H}-imidazol-4-yl)-2-[[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylamino]propyl] dihydrogen phosphate | Formula: | C14 H22 N4 O9 P2 | SMILES: | Cc1ncc(CO[P](O)(O)=O)c(CN[CH](CO[P](O)(O)=O)Cc2c[nH]cn2)c1O | InChi: | InChI=1S/C14H22N4O9P2/c1-9-14(19)13(10(3-16-9)6-26-28(20,21)22)5-17-12(7-27-29(23,24)25)2-11-4-15-8-18-11/h3-4,8,12,17,19H,2,5-7H2,1H3,(H,15,18)(H2,20,21,22)(H2,23,24,25)/t12-/m0/s1 | Definition date: | 2022-11-09 | Last modified: | 2024-09-27 | Release date: | 2023-03-22 | Identifier: | [(2~{S})-3-(1~{H}-imidazol-4-yl)-2-[[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylamino]propyl] dihydrogen phosphate |
|
| PHB | Name: | P-HYDROXYBENZOIC ACID | Formula: | C7 H6 O3 | SMILES: | O=C(O)c1ccc(O)cc1 | InChi: | InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 4-hydroxybenzoic acid |
|
| QNY | Name: | O-[(3S)-3-amino-3-carboxy-1,1-dihydroxypropyl]-L-threonine | Formula: | C8 H16 N2 O7 | SMILES: | O=C(O)C(N)C(OC(CC(C(O)=O)N)(O)O)C | InChi: | InChI=1S/C8H16N2O7/c1-3(5(10)7(13)14)17-8(15,16)2-4(9)6(11)12/h3-5,15-16H,2,9-10H2,1H3,(H,11,12)(H,13,14)/t3-,4+,5+/m1/s1 | Definition date: | 2019-11-26 | Last modified: | 2024-09-27 | Release date: | 2020-05-20 | Identifier: | O-[(3S)-3-amino-3-carboxy-1,1-dihydroxypropyl]-L-threonine |
|
| RGL | Name: | ARGINAL | Formula: | C6 H15 N4 O | SMILES: | O=CC(N)CCCNC(=[NH2+])N | InChi: | InChI=1S/C6H14N4O/c7-5(4-11)2-1-3-10-6(8)9/h4-5H,1-3,7H2,(H4,8,9,10)/p+1/t5-/m0/s1 | Definition date: | 2010-05-18 | Last modified: | 2024-09-27 | Identifier: | amino{[(4S)-4-amino-5-oxopentyl]amino}methaniminium |
|
| PHD | Name: | ASPARTYL PHOSPHATE | Formula: | C4 H8 N O7 P | SMILES: | O=C(OP(=O)(O)O)CC(C(=O)O)N | InChi: | InChI=1S/C4H8NO7P/c5-2(4(7)8)1-3(6)12-13(9,10)11/h2H,1,5H2,(H,7,8)(H2,9,10,11)/t2-/m0/s1 | Definition date: | 1999-10-06 | Last modified: | 2024-09-27 | Identifier: | 4-oxo-O-phosphono-L-homoserine |
|
| NSU | Name: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C13 H18 N4 O6 | SMILES: | OC(=O)CN(C1COCC1N)C(=O)CN1C=C(C)C(=O)NC1=O | InChi: | InChI=1S/C13H18N4O6/c1-7-2-16(13(22)15-12(7)21)3-10(18)17(4-11(19)20)9-6-23-5-8(9)14/h2,8-9H,3-6,14H2,1H3,(H,19,20)(H,15,21,22)/t8-,9-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2024-09-27 | Release date: | 2023-04-05 | Identifier: | N-[(3R,4R)-4-aminooxolan-3-yl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
| O7D | Name: | 4-methoxy-N-methyl-L-tryptophan | Formula: | C13 H16 N2 O3 | SMILES: | CNC(Cc1cnc2cccc(c12)OC)C(=O)O | InChi: | InChI=1S/C13H16N2O3/c1-14-10(13(16)17)6-8-7-15-9-4-3-5-11(18-2)12(8)9/h3-5,7,10,14-15H,6H2,1-2H3,(H,16,17)/t10-/m0/s1 | Definition date: | 2019-06-17 | Last modified: | 2024-09-27 | Release date: | 2020-05-13 | Identifier: | 4-methoxy-N-methyl-L-tryptophan |
|
| B8Z | Name: | ~{N}-(5,6-dimethoxy-1,3-benzothiazol-2-yl)-2-[(4-fluoranylphenoxy)methyl]-1,3-thiazole-4-carboxamide | Formula: | C20 H16 F N3 O4 S2 | SMILES: | COc1cc2sc(NC(=O)c3csc(COc4ccc(F)cc4)n3)nc2cc1OC | InChi: | InChI=1S/C20H16FN3O4S2/c1-26-15-7-13-17(8-16(15)27-2)30-20(23-13)24-19(25)14-10-29-18(22-14)9-28-12-5-3-11(21)4-6-12/h3-8,10H,9H2,1-2H3,(H,23,24,25) | Definition date: | 2022-03-26 | Last modified: | 2024-09-27 | Release date: | 2023-03-22 | Identifier: | ~{N}-(5,6-dimethoxy-1,3-benzothiazol-2-yl)-2-[(4-fluoranylphenoxy)methyl]-1,3-thiazole-4-carboxamide |
|
| TJB | Name: | 2-chloranyl-4-(2-phenylimidazol-1-yl)benzaldehyde | Formula: | C16 H11 Cl N2 O | SMILES: | Clc1cc(ccc1C=O)n2ccnc2c3ccccc3 | InChi: | InChI=1S/C16H11ClN2O/c17-15-10-14(7-6-13(15)11-20)19-9-8-18-16(19)12-4-2-1-3-5-12/h1-11H | Synonyms: | LvD1017 | Definition date: | 2020-12-22 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 2-chloranyl-4-(2-phenylimidazol-1-yl)benzaldehyde |
|
| PHE | Name: | PHENYLALANINE | Formula: | C9 H11 N O2 | SMILES: | O=C(O)C(N)Cc1ccccc1 | InChi: | InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-phenylalanine |
|
| WDB | Name: | (~{E})-3-[2-[(3-chlorophenyl)methyl]-4-oxidanylidene-3~{H}-quinazolin-7-yl]prop-2-enoic acid | Formula: | C18 H13 Cl N2 O3 | SMILES: | OC(=O)C=Cc1ccc2C(=O)NC(=Nc2c1)Cc3cccc(Cl)c3 | InChi: | InChI=1S/C18H13ClN2O3/c19-13-3-1-2-12(8-13)10-16-20-15-9-11(5-7-17(22)23)4-6-14(15)18(24)21-16/h1-9H,10H2,(H,22,23)(H,20,21,24)/b7-5+ | Definition date: | 2023-09-29 | Last modified: | 2024-09-27 | Release date: | 2024-10-02 | Identifier: | (~{E})-3-[2-[(3-chlorophenyl)methyl]-4-oxidanylidene-3~{H}-quinazolin-7-yl]prop-2-enoic acid |
|
| WUU | Name: | N-[(2,4-dichlorophenyl)methyl]-4-(2,5-dioxopyrrolidin-1-yl)benzamide | Formula: | C18 H14 Cl2 N2 O3 | SMILES: | Clc1ccc(CNC(=O)c2ccc(cc2)N2C(=O)CCC2=O)c(Cl)c1 | InChi: | InChI=1S/C18H14Cl2N2O3/c19-13-4-1-12(15(20)9-13)10-21-18(25)11-2-5-14(6-3-11)22-16(23)7-8-17(22)24/h1-6,9H,7-8,10H2,(H,21,25) | Definition date: | 2023-10-13 | Last modified: | 2024-09-27 | Release date: | 2024-06-26 | Identifier: | N-[(2,4-dichlorophenyl)methyl]-4-(2,5-dioxopyrrolidin-1-yl)benzamide |
|
| M66 | Name: | (1R,2S,5S)-3-{(2S)-2-(2,3-dihydro-1H-inden-2-yl)-2-[({(1S)-2,2-dimethyl-1-[(2-oxopiperidin-1-yl)methyl]propyl}carbamoyl)amino]acetyl}-6,6-dimethyl-N-{(1S)-1-[oxo(prop-2-en-1-ylamino)acetyl]butyl}-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C40 H58 N6 O6 | SMILES: | CCC[CH](NC(=O)[CH]1[CH]2[CH](CN1C(=O)[CH](NC(=O)N[CH](CN3CCCCC3=O)C(C)(C)C)C4Cc5ccccc5C4)C2(C)C)C(=O)C(=O)NCC=C | InChi: | InChI=1S/C40H58N6O6/c1-8-14-28(34(48)36(50)41-18-9-2)42-35(49)33-31-27(40(31,6)7)22-46(33)37(51)32(26-20-24-15-10-11-16-25(24)21-26)44-38(52)43-29(39(3,4)5)23-45-19-13-12-17-30(45)47/h9-11,15-16,26-29,31-33H,2,8,12-14,17-23H2,1,3-7H3,(H,41,50)(H,42,49)(H2,43,44,52)/t27-,28-,29+,31-,32-,33-/m0/s1 | Definition date: | 2010-01-04 | Last modified: | 2024-09-27 | Identifier: | (1R,2S,5S)-3-[(2S)-2-(2,3-dihydro-1H-inden-2-yl)-2-[[(2S)-3,3-dimethyl-1-(2-oxopiperidin-1-yl)butan-2-yl]carbamoylamino]ethanoyl]-N-[(3S)-1,2-dioxo-1-(prop-2-enylamino)hexan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|